CLINUVEL PHARMACEUTICALS financial statements, including revenue, expenses, profit, and loss
The total revenue of UR9 for the last semiannual is 19.90 M EUR, and it's 33.46% lower compared to the previous semiannual. The net income of H1 24 is 6.75 M EUR.